Julia von Oettingen1, Joseph Wolfsdorf2, Henry A Feldman3, Erinn T Rhodes2. 1. Division of Endocrinology, and julia.vonoettingen@childrens.harvard.edu. 2. Division of Endocrinology, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts. 3. Division of Endocrinology, and Clinical Research Center, Boston Children's Hospital, Boston, Massachusetts; and.
Abstract
OBJECTIVE: To investigate whether serum bicarbonate (HCO3) levels can be used to accurately diagnose diabetic ketoacidosis (DKA) and classify its severity in children with new-onset diabetes mellitus (NODM). METHODS: Retrospective study of all patients with NODM presenting to Boston Children's Hospital from October 1, 2007, to July 1, 2013. DKA was defined as blood glucose ≥200 mg/dL, venous pH (vpH) <7.3, and urine ketones ≥2+, and severe DKA as vpH <7.1. Linear regression was used to assess serum HCO3 as a predictor of vpH, and logistic regression to evaluate serum HCO3 as a predictor of DKA and severe DKA. RESULTS: Of 690 study cohort subjects (47% girls, age 10.8 ± 4.3 years, 76.7% white), 19.4% presented with DKA. The relationship between serum HCO3 and vpH was log-linear (r = 0.87, 95% CI 0.85-0.89, P < .001). HCO3 predicted vpH (R(2) 0.75, P < .001) using the formula vpH = 6.81301 + (0.17823*ln[HCO3]) and DKA and severe DKA (c-statistic 0.97 [95% CI 0.96-0.99, P < .001] and 0.99 [95% CI 0.991-0.999, P < .001], respectively). HCO3 cutoffs of <18 and <8 mmol/L had sensitivities of 91.8% and 95.2%, and specificities of 91.7% and 96.7%, respectively, to diagnose DKA and severe DKA. Findings were similar in a validation cohort of 197 subjects. CONCLUSIONS: Serum HCO3 concentration alone can substitute for vpH to diagnose DKA and classify severity in children with NODM. It is suggested as an alternative to reliance on vpH, especially in settings in which access to vpH measurement is limited.
OBJECTIVE: To investigate whether serum bicarbonate (HCO3) levels can be used to accurately diagnose diabetic ketoacidosis (DKA) and classify its severity in children with new-onset diabetes mellitus (NODM). METHODS: Retrospective study of all patients with NODM presenting to Boston Children's Hospital from October 1, 2007, to July 1, 2013. DKA was defined as blood glucose ≥200 mg/dL, venous pH (vpH) <7.3, and urine ketones ≥2+, and severe DKA as vpH <7.1. Linear regression was used to assess serum HCO3 as a predictor of vpH, and logistic regression to evaluate serum HCO3 as a predictor of DKA and severe DKA. RESULTS: Of 690 study cohort subjects (47% girls, age 10.8 ± 4.3 years, 76.7% white), 19.4% presented with DKA. The relationship between serum HCO3 and vpH was log-linear (r = 0.87, 95% CI 0.85-0.89, P < .001). HCO3 predicted vpH (R(2) 0.75, P < .001) using the formula vpH = 6.81301 + (0.17823*ln[HCO3]) and DKA and severe DKA (c-statistic 0.97 [95% CI 0.96-0.99, P < .001] and 0.99 [95% CI 0.991-0.999, P < .001], respectively). HCO3 cutoffs of <18 and <8 mmol/L had sensitivities of 91.8% and 95.2%, and specificities of 91.7% and 96.7%, respectively, to diagnose DKA and severe DKA. Findings were similar in a validation cohort of 197 subjects. CONCLUSIONS: Serum HCO3 concentration alone can substitute for vpH to diagnose DKA and classify severity in children with NODM. It is suggested as an alternative to reliance on vpH, especially in settings in which access to vpH measurement is limited.
Authors: David B Dunger; Mark A Sperling; Carlo L Acerini; Desmond J Bohn; Denis Daneman; Thomas P A Danne; Nicole S Glaser; Ragnar Hanas; Raymond L Hintz; Lynne L Levitsky; Martin O Savage; Robert C Tasker; Joseph I Wolfsdorf Journal: Pediatrics Date: 2004-02 Impact factor: 7.124
Authors: Joseph I Wolfsdorf; Jeremy Allgrove; Maria E Craig; Julie Edge; Nicole Glaser; Vandana Jain; Warren W R Lee; Lucy N W Mungai; Arlan L Rosenbloom; Mark A Sperling; Ragnar Hanas Journal: Pediatr Diabetes Date: 2014-07-12 Impact factor: 4.866
Authors: Melanie Rodacki; Joana Rodrigues Dantas Pereira; Aline Moreira Nabuco de Oliveira; Bianca Barone; Renata Mac Dowell; Paula Perricelli; Michelle Telles Bravo; Marcus Miranda de Oliveira; Julia Dias Brum; Luciana Camara Belem; Phelipe Guimarães de Ornellas; Renata Szundy Berardo; Jorge Luescher; Ludmila Campos; Andrea de Menezes Vangelotti; Rosane Kupfer; Lenita Zajdenverg; Adolpho Milech; Jose Egidio Paulo de Oliveira Journal: Diabetes Res Clin Pract Date: 2007-05-02 Impact factor: 5.602
Authors: Estevan Garcia; Thomas J Abramo; Pamela Okada; Daniel D Guzman; Joan S Reisch; Robert A Wiebe Journal: Crit Care Med Date: 2003-10 Impact factor: 7.598
Authors: Mae Sheikh-Ali; Brad S Karon; Ananda Basu; Yogish C Kudva; Lisa A Muller; Jia Xu; W Frederick Schwenk; John M Miles Journal: Diabetes Care Date: 2008-01-09 Impact factor: 19.112
Authors: Oğuz Eğil; Fatih Şap; Beray Selver Eklioğlu; Mehmet Burhan Oflaz; Mehmet Emre Atabek; Tamer Baysal Journal: J Clin Res Pediatr Endocrinol Date: 2021-08-18